Last reviewed · How we verify
NCT05060068
Effect of Intravenous S-ketamine on Opioid Consumption
NA trial testing S-ketamine (low dose) in Breast Cancer Surgery in 345 participants. Completed in 7 July 2024.
7 July 2024
Quick facts
| Lead sponsor | The Second Hospital of Anhui Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 345 |
| Start date | 7 October 2021 |
| Primary completion | 7 July 2024 |
| Estimated completion | 7 July 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- S-ketamine (low dose)
- Placebo
- S-ketamine (high dose)
Conditions studied
- Breast Cancer Surgery — all drugs for Breast Cancer Surgery →
Sponsor
The Second Hospital of Anhui Medical University
Who can join
Eligibility, female only, with Breast Cancer Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Female patients with an American Society of Anesthesia (ASA) physical status I-II, scheduled for elective breast cancer surgery will be included in the study. Subjects will be randomly assigned to one of three groups: the placebo group, the low-dose S-ketamine group, and the high-dose S-ketamine group. The primary outcome is the consumption of sufentanil during the surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05060068
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer Surgery
Currently open trials in the same condition.
- NCT06761196 — Quality of Life After Breast Cancer Surgery · recruiting
- NCT06958991 — Confocal Histolog Scanner in Routine Breast-Conserving Surgery (CHiB) · NA · recruiting
- NCT06906601 — Preoperative Magnetic Tracking in Breast Surgery in France: French Medical-economic Study. · recruiting
- NCT06888388 — Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast · recruiting
- NCT06966791 — Sexual Functıon in Young Women After Breast Cancer Surgery · recruiting
Other The Second Hospital of Anhui Medical University trials
Trials by the same sponsor.
- NCT07533773 — Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Elect · NA · not yet recruiting
- NCT07500064 — Transcranial Direct Current Stimulation for Depression · NA · not yet recruiting
- NCT07373132 — Effects of Aromatherapy on Sleep Quality in Hospitalized Elderly Female Patients With Insomnia · NA · not yet recruiting
- NCT07185022 — Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion · NA · recruiting
- NCT07023679 — Stellate Ganglion Morphine Infiltration on Myocardial I/R Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05060068 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Second Hospital of Anhui Medical University
- Last refreshed: 6 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05060068.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing